Wealthcare Capital Management LLC Acquires 252 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wealthcare Capital Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 42.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 852 shares of the healthcare conglomerate’s stock after buying an additional 252 shares during the period. Wealthcare Capital Management LLC’s holdings in UnitedHealth Group were worth $434,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the business. Lincoln National Corp grew its stake in UnitedHealth Group by 15.1% during the fourth quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock valued at $4,495,000 after acquiring an additional 1,174 shares in the last quarter. Salvus Wealth Management LLC grew its position in shares of UnitedHealth Group by 23.5% during the 1st quarter. Salvus Wealth Management LLC now owns 782 shares of the healthcare conglomerate’s stock valued at $399,000 after purchasing an additional 149 shares in the last quarter. YorkBridge Wealth Partners LLC increased its holdings in shares of UnitedHealth Group by 1.8% in the fourth quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock worth $7,681,000 after purchasing an additional 272 shares during the period. Alexandria Capital LLC boosted its stake in UnitedHealth Group by 3.5% during the third quarter. Alexandria Capital LLC now owns 17,100 shares of the healthcare conglomerate’s stock valued at $6,682,000 after buying an additional 584 shares during the period. Finally, BOKF NA increased its stake in UnitedHealth Group by 3.0% in the 4th quarter. BOKF NA now owns 87,046 shares of the healthcare conglomerate’s stock worth $43,709,000 after acquiring an additional 2,546 shares during the last quarter. Hedge funds and other institutional investors own 87.48% of the company’s stock.

Shares of UNH opened at $489.68 on Thursday. The firm’s 50-day simple moving average is $496.56 and its two-hundred day simple moving average is $490.86. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The stock has a market cap of $459.40 billion, a PE ratio of 26.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.83. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The business had revenue of $80.15 billion during the quarter, compared to analysts’ expectations of $78.77 billion. During the same quarter in the previous year, the business earned $5.31 earnings per share. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th will be issued a $1.65 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date is Thursday, June 16th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.35%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.12%.

In other news, Director Frederick William Mcnabb III acquired 89 shares of the business’s stock in a transaction that occurred on Thursday, May 26th. The stock was bought at an average price of $504.32 per share, with a total value of $44,884.48. Following the completion of the acquisition, the director now directly owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction dated Monday, May 16th. The stock was sold at an average price of $493.25, for a total value of $1,233,125.00. Following the completion of the transaction, the director now directly owns 1,220,000 shares in the company, valued at $601,765,000. The disclosure for this sale can be found here. Corporate insiders own 0.40% of the company’s stock.

A number of equities analysts have commented on the stock. Barclays boosted their price target on shares of UnitedHealth Group from $495.00 to $565.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 30th. Sanford C. Bernstein lowered UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target for the company. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Oppenheimer lifted their price target on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a research note on Monday, April 18th. Cowen raised their price objective on UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Finally, Credit Suisse Group increased their target price on UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a report on Monday, April 18th. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $555.73.

About UnitedHealth Group (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.